COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,587 Articles (22,415 medRxiv, 8,172 bioRxiv)

Most recent first Previous |  Page 1042: Articles 10411-10420  | Next

Community healthcare workers' experiences during and after COVID-19 lockdown: a qualitative study from Aotearoa New Zealand
HOLROYD, E., LONG, N. J., APPLETON, N. S., DAVIES, S. G., DECKERT, A., FEHOKO, E., LAWS, M., MARTIN-ANATIAS, N., SIMPSON, N., STERLING, R., TRNKA, S., TUNUFA'I, L.
10.1101/2021.11.26.21266650 — Posted: 2021-11-28
A fourth dose of the mRNA-1273 SARS-CoV-2 vaccine improves serum neutralization against the delta variant in kidney transplant recipients
Benotmane, I., Bruel, T., Planas, D., Fafi-Kremer, S., Schwartz, O., Caillard, S.
10.1101/2021.11.25.21266704 — Posted: 2021-11-28
Development and Implementation of Dried Blood Spot-based COVID-19 Serological Assays for Epidemiologic Studies
Wong, M. P., Meas, M., Adams, C., Hernandez, S., Green, V., Montoya, M., Hirsch, B. M., Horton, M., Quach, H., Quach, D., Shao, X., Fedrigo, I., Zermeno, A., Huffaker, J., Montes, R., Madden, A., Cyrus, S., McDowell, D., Williamson, P., Contestable, P., Stone, M., Coloma, J., Busch, M. P., Barcellos, L., Harris, E.
10.1101/2021.11.25.21266786 — Posted: 2021-11-28
Relationships among High School Student-Athletes' Mental Health, Stressors, and Social Support during the COVID-19 Pandemic in Japan
Yamaguchi, K., Katagami, E., Shinohara, R., Tsuji, T., Yamagata, Z., Tsuchiya, H.
10.1101/2021.11.25.21266885 — Posted: 2021-11-28
Analytical sensitivity and effectiveness of different SARS-CoV-2 testing options
Lelie, N., Koppelman, M., Van Drimmelen, H., Bruisten, S.
10.1101/2021.11.26.21265946 — Posted: 2021-11-28
A generic method and software to estimate the transmission advantage of pathogen variants in real-time : SARS-CoV-2 as a case-study
Bhatia, S., Wardle, J., Nash, R. K., Nouvellet, P., Cori, A.
10.1101/2021.11.26.21266899 — Posted: 2021-11-28
Dosing interval strategies for two-dose COVID-19 vaccination in 13 low- and middle-income countries of Europe: health impact modelling and benefit-risk analysis
Liu, Y., Pearson, C. A., Sandmann, F. G., Barnard, R. C., Kim, J.-H., CMMID COVID-19 Working Group, , Flasche, S., Jit, M., Abbas, K.
10.1101/2021.11.27.21266930 — Posted: 2021-11-28
Variations of the quality of care during the COVID-19 pandemic affected the mortality rate of non-COVID patients with hip fracture
Golinelli, D., Sanmarchi, F., Capodici, A., Gribaudo, G., Altini, M., Rosa, S., Esposito, F., Fantini, M. P., Lenzi, J.
10.1101/2021.11.27.21266927 — Posted: 2021-11-28
The relationship of COVID-19 related stress and media consumption with schizotypy, depression and anxiety
Daimer, S., Mihatsch, L., Neufeld, S. A., Murray, G. K., Knolle, F.
10.1101/2021.11.26.21266896 — Posted: 2021-11-28
Synthesis of High-Resolution Research-Quality MRI Data from Clinical MRI Data in Patients with COVID-19
Cali, R. J., Freeman, H. J., Billot, B., Barra, M. E., Fischer, D., Sanders, W. R., Huang, S. Y., Conklin, J., Fischl, B., Iglesias, J. E., Edlow, B. L.
10.1101/2021.11.25.21266090 — Posted: 2021-11-26

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).